Literature DB >> 15653685

HIV-1 Nef disrupts antigen presentation early in the secretory pathway.

Matthew R Kasper1, Jeremiah F Roeth, Maya Williams, Tracey M Filzen, Rebekah I Fleis, Kathleen L Collins.   

Abstract

Human immunodeficiency virus, type 1 Nef disrupts viral antigen presentation and promotes viral immune evasion from cytotoxic T lymphocytes. There is evidence that Nef acts early in the secretory pathway to redirect major histocompatibility complex class I (MHC-I) from the trans-Golgi network to the endolysosomal pathway. However, a competing model suggests that Nef acts much later by accelerating MHC-I turnover at the cell surface. Here we demonstrate that Nef targets early forms of MHC-I molecules in the endoplasmic reticulum by preferentially binding hypophosphorylated cytoplasmic tails. The Nef-MHC-I complex migrates normally into the Golgi apparatus but subsequently fails to arrive at the cell surface and become phosphorylated. Cell type-specific differences in the rate of MHC-I transport through the secretory pathway correlate with responsiveness to Nef and co-precipitation of adaptor protein 1 with the Nef.MHC-I complex. We propose that the assembly of a Nef.MHC-I.adaptor protein 1 complex early in the secretory pathway is important for Nef activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15653685     DOI: 10.1074/jbc.M413538200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  HIV-1 Nef binds a subpopulation of MHC-I throughout its trafficking itinerary and down-regulates MHC-I by perturbing both anterograde and retrograde trafficking.

Authors:  Ling Yi; Tilman Rosales; Jeremy J Rose; Bhabadeb Chowdhury; Bhabhadeb Chaudhury; Jay R Knutson; Sundararajan Venkatesan
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

2.  The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways.

Authors:  Jianmin Zuo; Laura L Quinn; Jennifer Tamblyn; Wendy A Thomas; Regina Feederle; Henri-Jacques Delecluse; Andrew D Hislop; Martin Rowe
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

3.  A noncanonical mu-1A-binding motif in the N terminus of HIV-1 Nef determines its ability to downregulate major histocompatibility complex class I in T lymphocytes.

Authors:  Sayuki Iijima; Young-Jung Lee; Hirotaka Ode; Stefan T Arold; Nobuyuki Kimura; Masaru Yokoyama; Hironori Sato; Yasuhito Tanaka; Klaus Strebel; Hirofumi Akari
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

Review 4.  Viral evasion of the MHC class I antigen-processing machinery.

Authors:  Sandra Loch; Robert Tampé
Journal:  Pflugers Arch       Date:  2005-08-06       Impact factor: 3.657

5.  A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2.

Authors:  O Wolf Lindwasser; William J Smith; Rittik Chaudhuri; Peter Yang; James H Hurley; Juan S Bonifacino
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

Review 6.  Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway.

Authors:  Antony N Antoniou; Simon J Powis
Journal:  Immunology       Date:  2008-02-18       Impact factor: 7.397

7.  HIV-1 Nef disrupts intracellular trafficking of major histocompatibility complex class I, CD4, CD8, and CD28 by distinct pathways that share common elements.

Authors:  Jolie A Leonard; Tracy Filzen; Christoph C Carter; Malinda Schaefer; Kathleen L Collins
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

8.  HIV-1 Nefs Are Cargo-Sensitive AP-1 Trimerization Switches in Tetherin Downregulation.

Authors:  Kyle L Morris; Cosmo Z Buffalo; Christina M Stürzel; Elena Heusinger; Frank Kirchhoff; Xuefeng Ren; James H Hurley
Journal:  Cell       Date:  2018-07-26       Impact factor: 41.582

9.  Efficient Vpu-Mediated Tetherin Antagonism by an HIV-1 Group O Strain.

Authors:  Katharina Mack; Kathrin Starz; Daniel Sauter; Simon Langer; Frederic Bibollet-Ruche; Gerald H Learn; Christina M Stürzel; Marie Leoz; Jean-Christophe Plantier; Matthias Geyer; Beatrice H Hahn; Frank Kirchhoff
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

Review 10.  Structure, function, and inhibitor targeting of HIV-1 Nef-effector kinase complexes.

Authors:  Ryan P Staudt; John J Alvarado; Lori A Emert-Sedlak; Haibin Shi; Sherry T Shu; Thomas E Wales; John R Engen; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2020-08-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.